InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-6.5%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by GARRETT SCOTT T, Director. Insider active across 2 companies, notably HCW Biologics Inc.. Cumulatively, 13 filings have been recorded. Split: 5 buys · 2 sells. Total volume traded: €3.5m. Activity tracked since 22 July 2021. The latest transaction was filed on 22 May 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
177,936 shares@ US$1.4052.62% mcap9.3% of flowCommon StockSEC:0001493152-26-025476:0
Ideal exit: 16 Feb 2027 (T+270)
13,423 shares@ US$7.453.9% of flowCommon StockSEC:0000950170-25-075252:0
Ideal exit: 10 Feb 2026 (T+270)
5,385 shares@ US$26.005.4% of flowCommon StockSEC:0000950170-25-068287:0
Ideal exit: 2 Feb 2026 (T+270)
9,039 shares@ US$26.7413.9% of flowCommon StockSEC:0001127602-24-010261:0
1,572 sharesCommon StockSEC:0001127602-24-009438:0
142,858 shares@ US$1.408.0% of flowCommon StockSEC:0001209191-24-003784:0
10,000 shares@ US$68.711640.2% of flowCommon StockSEC:0001127602-23-029562:0
10,000 shares@ US$79.72445.9% of flowCommon StockSEC:0001127602-23-019032:0
1,465 sharesCommon StockSEC:0001127602-23-009868:0
1,565 sharesCommon StockSEC:0001127602-22-009131:0
125,000 shares@ US$8.0036.7% of flowCommon StockSEC:0001209191-21-048084
Ideal exit: 18 Apr 2022 (T+270)
125,000 shares@ US$8.0010.34% mcap50.0% of flowCommon StockSEC:0001209191-21-048084:0
Ideal exit: 18 Apr 2022 (T+270)
3,272 sharesCommon StockSEC:0001127602-16-036069:0
13 of 13 declarations
About GARRETT SCOTT T
GARRETT SCOTT T is a Board Member of HCW Biologics Inc. and HOLOGIC INC. He plays a key role in overseeing the company's activities, bringing his expertise in biotechnology and management. His involvement is essential for the strategic development of the organization.
